Judy Foreman

Nationally Sindicated Fitness, Health, and Medicine Columnist

  • HOME
  • Books
  • BIO
  • BLOG
  • COLUMNS
  • Q&A
  • PRESS
  • CONTACT

Column Search

Column Categories

  • General Medicine
  • Women's issues
    • Breast Cancer
    • Hormone replacement
  • Cancer
  • Alternative Medicine
  • Nutrition
  • Exercise/Fitness
  • Heart Disease
  • Aging
  • Pain
  • Dental
  • Allergies
  • Mental Health
    • Depression
    • Alcohol
    • Loneliness/Loss
    • Sleep Problems
    • Anxiety

The Gender Gap

September 27, 2010 by Judy Foreman

Learning why men and women experience pain differently

It’s one of the more puzzling observations in medicine: The vast majority of chronic pain patients are women. Women suffer disproportionately from irritable bowel syndrome, fibromyalgia, headaches (especially migraines), pain caused by damage to the nervous system, osteoarthritis, jaw problems like TMJ, and much more. Women also report more acute pain than men after the same common surgeries.

In the lab, when researchers ask male and female volunteers to subject themselves to experimental pain — increasingly hot stimulation on the inner arm, immersion of the hand in very cold water, electrical jolts to the skin — women show lower pain thresholds (that is, they report pain at lower levels of stimulus intensity) and lower tolerance (they can’t bear intense pain as long).

Women are also better able to detect small gradations in pain stimuli. And they respond differently to certain opioid — painkilling — drugs. (It’s not clear whether men and women differ in sensitivity to cancer pain.)

But it’s only recently that researchers have begun to study the exact genetic, physiological, hormonal, and psycho-social factors that may underlie these sex differences. In part, that’s because pain researchers have been hampered by one — rather shocking — fact: Most basic pain research is still done in male mice and rats.

This has been “a catastrophe,” says McGill University pain geneticist Jeffrey Mogil, adding that the old rationale that menstrual cycles make females too difficult to study is bogus. Men and women, in fact, can be so different in the way their nervous systems process pain that someday there may be “pink pills for women, and blue pills for men,” he says. The lopsided research exists solely because of “inertia,” he adds.

Others agree, among them Dr. Roger B. Fillingim, lead author of an exhaustive 2009 review of sex and pain research published by the American Pain Society. In that paper, Fillingim, a pain researcher at the University of Florida, notes that while the National Institutes of Health now require routine inclusion of both sexes in human studies, much animal research “continues to eschew females.” Given that pain is mainly a female problem, he adds, this means research “that excludes females is incomplete at best and invalid at worst.”

Luckily, this shutout is not total, and of course, some human research does specifically address sex differences — with complex, and fascinating results.

Take hormones. Growing up, boys and girls show comparable patterns of pain until puberty, notes Dr. Navil Sethna, a pediatric anesthesiologist at Children’s Hospital Boston. “After puberty, certain types of pain are more common in girls, and even if the incidence is the same, reported pain severity is more intense in girls than boys, especially for headaches and abdominal pain,” says Sethna. This pattern persists through adulthood; the lifetime prevalence for migraines is 18 percent for women and 6 percent for men.

The same pattern holds for TMJ, temporomandibular joint disease — now called TMD — with no sex differences before puberty and significant differences afterward.

Not all studies agree, but many do show that after puberty, women experience striking fluctuations in their response to pain at different points in the menstrual cycle. This has been noted in irritable bowel syndrome, TMD, headache, and fibromyalgia. One explanation, some researchers say, is that estrogen protects against pain at high levels, and enhances it at low levels. (The male hormone testosterone seems to protect against pain.)

This theory fits with the observation that during pregnancy, when estrogen levels are high, women often get fewer migraines and TMD pain. And it fits with the observation that, after childbirth, when estrogen falls abruptly, the number of migraine attacks increases.

It may not be the absolute level of estrogen that is key, says Dr. Fernando Cervero, a pain researcher at McGill, but the fluctuations in hormonal levels during the menstrual cycle. (Estrogen levels climb in the first half of the cycle, then decline in the second half.) “It’s the change that produces the change” in perceptions of pain, he says.

What about that big hormonal change, menopause? That’s when estrogen falls abruptly. If the low estrogen-more pain theory is true, women should experience pain after menopause, but research results are all over the place.

Several studies have shown that women who combat low levels of estrogen by taking hormone replacement therapy actually have more back pain and more pain from TMD as well. Other studies detect no link between hormone replacement therapy and pain in older women. And still others show that when women taking hormone replacement therapy, their pain appears to go up and they may get more migraines.

Females “may have evolved sensory mechanisms that allow for greater acuity across sense organs” over the eons, says Dr. William Maixner, director of the Center for Neurosensory Disorders at the University of North Carolina, Chapel Hill. Females are more sensitive in general to changes in smell, temperature, visual cues, and other stimuli that may signal danger — traits that could have helped them in earlier times to protect the children they watched while the men were away. Experiencing pain in a more heightened way may be one more example of that sensitivity.

“The conditions that cause pain affect men and women differently in terms of prevalence and severity,” notes Dr. Daniel Carr, a professor of pain research at Tufts Medical Center. Some drugs also affect men and women differently. And then there’s “the whole social dimension and cultural dimension of being a woman versus being a man, which modifies” treatment choices. In other words, he says, “Whatever pain therapy one selects should have some flexibility to it.”

One thing is clear: In this culture, women are often encouraged to express pain, and men to hide it. But this doesn’t mean that friends, relatives — and doctors — react sympathetically to women’s expression of pain. In the clinic, this often translates to gender bias and under-treatment of pain, notes Fillingim.

Women, he says, should not put up with any doctor who says or implies that “you are just another whining woman.” But neither, he adds, should men stick with doctors who don’t respect them or believe their pain.

“There are doctors with a greater understanding of pain in general and a greater willingness to deal with it, and others who, if they can’t see it on an X-ray, don’t believe it’s real,” Fillingim adds. Bottom line? “Avoid that latter category.”

This is Judy Foreman’s last Health Sense column for a while. She is writing a book on chronic pain, provisionally titled “A Nation in Pain: Treating Our Biggest Health Problem.” She invites readers to send their personal stories of pain to:judyforeman@myhealthsense.com

The Big Thaw

July 26, 2010 by Judy Foreman

Freezing human eggs is gaining in popularity, but declaring it a success would be premature

Doctors have been freezing sperm for 60 years and embryos (fertilized eggs) for 30. The first pregnancy from a frozen egg occurred in 1986.

But it’s been only in the past few years that fertility specialists have begun freezing eggs with any regularity — so short a time that two major professional groups, the American College of Obstetricians and Gynecologists and the American Society for Reproductive Medicine, still consider egg freezing experimental. They caution that a request to freeze eggs should be considered by an institutional review board before being granted.

Freezing eggs for non-medical reasons — a healthy woman choosing to harvest and preserve her eggs for conceiving a baby sometime in the future — is new enough that there are few reliable statistics on how successful the procedure is. “Success” in such cases means a take-home baby, not just an egg that is frozen without damage, or thawed safely, or even fertilized to yield a genetically normal, healthy embryo.

“So few women who have frozen eggs have come back to use them [that it’s impossible] to quote a clear pregnancy rate on it,” says Dr. Elizabeth Ginsburg, medical director of assisted reproductive technologies at Brigham and Women’s Hospital. There hasn’t been time to collect enough data, since women usually plan to freeze eggs for many months or years before retrieving them for conception.

But the idea is clearly catching on. Nationwide, roughly half of 282 US fertility centers surveyed offer egg freezing, according to researchers at the University of Southern California, who conducted the study and published findings last month in Fertility and Sterility, a journal of the American Society for Reproductive Medicine. There are about 400 fertility centers in the United States.

Egg freezing, not usually covered by insurance, can cost $10,000 or more per procedure. Beyond the initial expense, there are annual fees, often hundreds of dollars, to maintain the eggs.

At Boston IVF, a leading fertility cen ter in the United States and one of the oldest as well, typical fees are $6,000 for the harvesting and freezing of eggs, which does not cover the cost of hormones and medications, egg thawing, subsequent fertilization, or transfer of eggs to the uterus. The center has begun offering seminars on the process to young women, many of whom are just out of college or grad school and heading into the workforce.

A woman who decides on egg freezing is given hormones to stimulate egg production. At Boston IVF, egg retrieval is performed under general anesthesia, though other centers may use IV sedation plus pain-killing drugs.

Two-thirds of the clinics in the USC survey reported that they made the service available to women for elective reasons. Traditionally, egg freezing “has been used in women with cancer who face imminent loss of ovarian function. But recently, the technology has advanced to the point where it is worth using for women who want to preserve their oocytes for social reasons,” says Dr. Briana Rudick, a reproductive endocrinologist at the University of Southern California and the lead author of the survey.

There are no reliable numbers for how many women have chosen to have their eggs frozen so far. About 60 women have done so at Boston IVF, most of them as a hedge against their advancing age, says Dr. Kim Thornton, clinical director of the center’s egg-freezing program. So far, none has returned for the next step, she said.

Worldwide, more than 900 babies have been born from frozen eggs, according to a 2009 study conducted by researchers at the New York University Fertility Center, and published last year in Reproductive BioMedicine Online.

Of course, there are no guarantees that freezing eggs will preserve fertility, just as there are no guarantees — at any age — that a woman can get pregnant naturally. In both cases, the odds get worse as egg quality declines with age.

“Humans are the poorest of all mammalian species in terms of chromosomal integrity,” says Dr. Geoffrey Sher, founder of the Sher Institutes for Reproductive Medicine in Las Vegas. “With humans, even when they’re young, there’s only a 2 in 5 chance that an egg is normal. By the time a woman is 45, approximately 1 in 15 is normal.”

“Pregnancy rates at age 40 are pretty low even with fresh eggs,” says Ginsburg, at Brigham and Women’s. “You can chop that by two-thirds if it’s frozen eggs.”

Still, several advances are nudging the use of egg-freezing forward. One is “vitrification,” in which eggs are frozen within 15 minutes. Typically, eggs have been frozen slowly, over several hours, using programmable freezers that drop temperatures step by step. While many fertility clinics still use this method, ice crystals can form, making egg survival only about 60 percent, says Michael Tucker, scientific director at Georgia Reproductive Specialists in Atlanta. The claim with vitrification is that the egg survival rate may rise to 80 percent or even higher.

Testing the genetic viability of both eggs and embryos has also boosted interest in freezing. Several methods are available, including CGH, or comparative genomic hybridization, which checks eggs or embryos to be sure they have the correct number of chromosomes. Some embryos appear normal under the microscope but have the wrong number of chromosomes, meaning they are not viable, says Sher of Las Vegas.

Bottom line, a woman who wants to conceive a child at some point in the future should carefully consider the options — the risks, costs, and unknowns.

Regarding the use of egg freezing, Ginsburg advises not waiting too long. “If you want to have a child and it’s feasible socially, do it. . . . I get infertile patients, married for five years, who couldn’t imagine having a baby in [their] small apartment. That’s a bad reason to wait until age 35. It’s really sad, and I see it a lot.”

High Water Marks

June 14, 2010 by Judy Foreman

There’s no question swimming is good for you. Is it better than running or walking? Not so fast.

 Is swimming the best exercise for lifelong health?

After all, you can swim with just your arms if you have a bum knee, or with just your legs if you have sore arms. You can swim with arthritis. Or a recently replaced hip.

An article in the May-June 2010 issue of SWIMMER floats the notion that swimming just might be a life preserver. The report is based on the first major study comparing the long-term benefits of swimming with other activities, which concluded that “swimmers had lower mortality rates than those who were sedentary, walkers or runners.”

The research was conducted by Steven Blair, a leading exercise scientist from the University of South Carolina, and funded by the National Institutes of Health and the National Swimming Pool Foundation. It appeared in the International Journal of Aquatic Research and Education, a peer-reviewed journal published by Human Kinetics and the foundation. The 2008 study followed 40,547 men ages 20-90 who completed health exams between 1971 and 2003.

But is swimming really better for you? And if so, why?

Blair himself, in a telephone interview, is cautious. The 13-year study, he says, does “show that swimmers have lower death rates” than sedentary people, walkers, and runners. “That’s what the data show.” But are swimmers more fit than runners? “It doesn’t quite make sense to me,” he says and laughs.

Over the course of the research, 1,336 of the 20,356 runners (or 6.6 percent) had died, compared with only 11 of the 562 swimmers (1.9 percent). But the number of swimmers was so small that if a few more had died, it could have significantly changed the conclusions, he says.

In addition, the study was “observational,” that is, the researchers simply followed the different groups of people over time to see how they fared, as opposed to randomly assigning them to different types of exercise — a more rigorous way to conduct research.

“My guess is that there were a lot of differences between people who chose to be swimmers instead of runners or walkers. Swimmers may have been healthier to begin with so their lower death rate may have had nothing to do with swimming,” says Dr. Steven Woloshin, a professor of medicine at the Dartmouth Institute who analyzes the interpretation of scientific studies.

The study had other limitations: Only men were studied. It also didn’t track whether participants continued with the exercise they were doing at the start of the study period. And while the study did classify the runners and walkers by pace, it didn’t specify swim ming paces at all — no differentiation was made between the swimmers who dogpaddle a bit and never get their hair wet, and those who are dynamos in the water.

Still, after the authors adjusted their findings for differences in age, weight, smoking status, and other risk factors, the swimmers had lower all-cause mortality than the men who were sedentary, walkers, or runners.

In another 2008 study led by Blair, of men and women subjects using treadmill tests and other measures of cardiorespiratory fitness, runners scored the best, with swimmers a close second.

On the downside for swimming, one of its chief benefits — being weightless in the water, a boon for aching joints — can also be a disadvantage.

“Swimming does not build bone” like running does, says Dr. Michael Holick, an osteoporosis expert at the Boston University School of Medicine. “It’s pounding the pavement that is translated to hip and spine bone strength. Even treadmills and elliptical machines are not the same.”

On the other hand, he says, “there’s no evidence that swimming makes [bone loss] worse.” And swimmers do develop good muscles, and muscle mass “usually equates with higher bone density.”

The most important message of all the research is that physical activity of any sort is crucial for good health and longer life.

“There are so many things people can do for physical activity,” says I-Min Lee, an epidemiologist at Harvard Medical School who studies physical activity and health. “You can pick what you like. We’re not forcing everybody to run or play tennis.”

Blair’s findings about the benefits of swimming are “encouraging, though by no means definite,” Lee says.

Peter Katzmarzyk, a professor of epidemiology at the Pennington Biomedical Research Center in Baton Rouge, La., who also studies exercise and health, agrees. “I can’t say everybody should be swimming as opposed to other things,” he says. But at the very least, the study shows that swimming “accrues the same benefits as other activities, and that was never shown before.”

A sedentary lifestyle is a major risk factor for premature mortality from all causes. It’s also a risk for many chronic diseases, including Type 2 diabetes, cardiovascular disease, and cancer.

Put the other way around, people who expend more than 1,000 calories a week in exercise cut their risk of dying — from all causes — by 20 to 30 percent, and those who do more cut their risk even more. Physically active people have lower (healthier) fasting blood glucose levels and insulin resistance, and are better able to control their weight. They also have lower blood pressure, total cholesterol, and “bad” low-density cholesterol.

As for swimming as an exercise choice, more research is needed. But the data so far suggest that it’s right up there with running as a great way to get and stay fit. And it’s certainly easier on the knees, a huge advantage for many people as they age.

Besides, there really is something about sliding into the water, outdoors or in a pool, and moving quietly along. After all, life evolved in the water. Why not head back in?

 

Those Restless Legs…

May 17, 2010 by Judy Foreman

Restless legs syndrome keeps you going (even if you want to
stop).

The symptoms of restless legs syndrome sound so bizarre —
creepy-crawly feelings and an uncontrollable urge to move the legs, especially
at bedtime — that until recently, many people who experienced it simply weren’t
believed when they described it to others.

Betsy Dunn, an 85-year-old Cambridge businesswoman who has had
restless legs for nearly 30 years, remembers a doctor saying she must be
depressed. “I walked out and never went back,” she says. “All I needed him to
say was, ‘I don’t know what this is, but together we will find out.’ ”

In severe cases, like that of Donald Loveland, 75, a retired Duke
University computer scientist now living in Dennis, the urge to move the legs
overwhelms everything else, including pain. Right after back surgery, he
recalls, “it was actually painful to be up but I had to get up anyway.”

Ron Blum, 38, a Jamaica Plain e-mail marketer who first noticed
his symptoms as a 7-year-old, recalls that the minute he lay down and tried to
sleep, “my left leg felt like it had to go for a walk.” Though he never told
his parents, he’d get up and walk for hours in circles. It wasn’t until years
later that a friend heard about RLS. “He called me up and said, ‘Ron, I know
what you have. It has a name.’ ”

It also has growing recognition. RLS may affect some 12 million Americans, according to the National Institute of Neurological Disorders and Stroke, as reported on the
National Institutes of Health website (www.ninds.nih.gov/disorders).
The NIH supports research into the condition at major medical institutions
across the country, as well as within its own labs.

The NIH report notes that the number of RLS sufferers may be even
higher than estimated. Some people with the condition don’t seek medical
attention, believing that they will not be taken seriously, that their symptoms
are too mild, or that their condition is not treatable. Some physicians wrongly
attribute the symptoms to nervousness, insomnia, stress, arthritis, muscle
cramps, or aging.

“You can think of RLS today as where sleep apnea was 10 to 15
years ago,” says Dr. John Winkelman, a psychiatrist, RLS expert, and medical
director of Sleep Health Centers, which is affiliated with Brigham and Women’s
Hospital.

“We used to think of sleep apnea as a bunch of fat guys snoring,”
says Winkelman, who consults for drug companies that make RLS medications. “We
are also just beginning to recognize the potential negative medical
consequences of RLS.” A number of studies have hinted that the syndrome might
be associated with more serious conditions.

Not to mention the toll RLS takes on the quality of life.

“There were many, many nights when I would sleep for only two and
a half or three hours,” recalls Roberta Kittredge, a 65-year old retired
teacher in Hampton, N.H., who first got RLS when she was pregnant. (Some
studies suggest a link between RLS and high estrogen levels.) “Every night I
went to bed positive I would sleep, and two or three minutes later, I was out
of bed and walking the floor for hours and hours.”

There is currently no single diagnostic test for RLS.

“We know what’s wrong,” says Richard Allen, an associate
professor of neurology at Johns Hopkins University. “The neurobiology of RLS is
definitely clear.”

Levels of iron fall too low in parts of the brain, resulting in
reduced availability of dopamine, a neurotransmitter that carries information
between the body’s cells involved with movement that is also deficient in such
disorders as Parkinson’s disease. In addition, four genes have been linked to
RLS, which often appears in families.

The dopamine connection helps explain why RLS has such a distinct
circadian rhythm, says Allen, who also consults for companies that make RLS
drugs. Dopamine levels follow a clear 24-hour pattern, with levels lowest in
the evening. Moreover, presumably because both RLS and Parkinson’s involve low
dopamine, some of the dopamine-enhancing drugs used to treat Parkinson’s — like
Mirapex and Requip — also can reduce or eliminate RLS symptoms in some
patients. Side effects may include nausea and headache. Taking iron supplements
has been helpful in decreasing or halting RLS symptoms for some patients.

“I would probably be dead by now because of exhaustion,” says
retired Newton architect Paul Dudek, 70, whose life improved dramatically when
he was finally diagnosed and treated with medication.

Dopamine also plays an important role in erectile function, and
epidemiologist Xiang Gao of the Harvard School of Public Health has shown that
men with relatively severe RLS have nearly double the normal risk of erectile
dysfunction. (Xiang Gao has no ties to RLS drug companies.)

But dopamine isn’t the only neurotransmitter that plays into the
RLS picture. Histamine, for one, is a powerful brain stimulant, so drugs that
block histamine — antihistamines such as Benadryl — can significantly
exacerbate RLS symptoms.

One of the frustrations with RLS is that symptoms are usually
triggered just when a person needs to sit or lie still, such as on long plane
trips or when sitting in the audience at concerts and other presentations.
Symptoms tend to be most severe at night.

Once asleep, 80 percent of people with RLS also exhibit another
condition: periodic limb movement during sleep (PLMS), in which the legs jerk
as often as every 20 or 30 seconds. Researchers from the University of Montreal
and elsewhere have shown that each involuntary PLMS leg movement is associated
with a dramatic increase in blood pressure.

Studies suggest RLS might be associated with more serious medical
problems, such as increased risk of heart disease and stroke.

If a link between RLS and high blood pressure is confirmed, the impact
would be dramatic. “Hypertension is a powerful predictor of premature death,”
says Dr. David Rye, a neurologist at Emory University who studies the genetics
of RLS and PLMS and has the conditions himself. Rye also consults with
companies that make RLS drugs.

So far, though a number of researchers have noted associations
between RLS and other diseases, no one has established causality between RLS
and the other conditions. RLS is not an established risk factor for
cardiovascular disease in the way that cholesterol is, for example.

While understanding the condition is a complicated task, RLS
patient Kittredge can offer some hard-won advice to people who might be
suffering in silence and shame: “Find an educated doctor . . . who understands
RLS,” she says. “There is hope out there. I am living proof.”

 

Trick or Treatment?

February 6, 2006 by Judy Foreman

A spate of recent studies reinforces the idea that what we think about our
medical care really can affect our health.

The new research into the power of placebos is giving scientists new
insights into how patients’ expectations their beliefs about whether an
inactive, sham treatment will work can have an actual, observable effect on
their well-being.

In one small study, volunteers with jaw pain were repeatedly injected with
what they were told was a pain drug but in reality was nothing but salt
water, yet PET scans showed that after every injection, their brains
produced endorphins natural, opiate-like painkillers.

The men’s beliefs about the treatment caused changes in the brains and
reduced their perception of pain, said Dr. Jon-Kar Zubieta, the study
leader and associate professor of psychiatry and radiology at the
University of Michigan Medical School.

The placebo effect can work in reverse, too, through its evil twin, the
“nocebo” effect. At least 25 percent of the time, when people take an
inactive placebo they report experiencing side effects like headache,
insomnia, and fatigue, said Dr. Arthur Barsky, a psychiatrist at Brigham
and Women’s Hospital. In other words, telling patients about potential side
effects can make it more likely that they’ll occur.

And last week, Harvard researchers reported that sham acupuncture provides
more pain relief than a sugar pill that comes with a promise of relief. The
conclusion to draw from the study, said researcher Ted Kaptchuk, is that
medical ritual “may be a critical component” of treatment.

The work on placebos will help researchers determine precisely what their
drugs are doing and what the contribution of the placebo effect is for
healing though it’s still unclear precisely how best to harness the placebo
effect to make patients feel better.

“The whole point of all this is, how do we capitalize on the placebo
response,” said Dr. Helen Mayberg, a professor of psychiatry and neurology
at Emory University School of Medicine.

The research shows that it’s not possible to “psych yourself” into making a
drug work. But not trusting your care whether it’s popping a pill handed to
you by a doctor or undergoing 30 minutes of treatment from an alternative
medicine practitioner is likely to undermine any benefits.

“This is not about the power of positive thinking, it’s about positive
expectations,” Mayberg said. “I can’t think myself well, but if you go in
with a new treatment and say, `This is not going to work,’ it probably
won’t help you.”

In general, from 30 to 60 percent of patients with everything from
arthritis to depression report an improvement in symptoms after receiving a
placebo. One-third of depressed people feel better after taking placebos,
while 50 to 60 percent of those taking antidepressants do, said Dr. Andrew
Leuchter, vice chairman of the department of psychiatry at the University
of California, Los Angeles.

“The placebo effect is the summation of all the things we do in treatment
that help people get better that are not part of a known specific
treatment,” he said.

“I define it that broadly because when we interact with someone in a
positive way, when we give them encouragement and support, and also when
they become part of the healthcare system no longer sitting at home ill,
but in a milieu where they are getting treatment we tap into positive
expectations.”

The effects of placebos wear off with time, but real drugs keep on working.

Because of this and medical ethics no one is suggesting that doctors
prescribe their patients sugar pills or sham treatments.

But combining real medicines with the “placebo effect” does more than
either can alone.

“The take-home message is that when you get an active drug, you get the
effect of the drug itself and the placebo effect,” said Michigan’s Zubieta.

The newest research, much of it based on brain imaging techniques, provides
direct evidence of how the placebo effect works. The research will help
scientists determine more precisely the contributions of the “placebo
response” to the effectiveness of medications.

Some other recent findings:

Columbia University researcher Tor Wager has used brain scans to map where
in the brain the placebo response occurs. It turns out that those areas
including the thalamus, the insula, and the anterior cingulate cortex are
also among the areas activated when a person is in pain.

The placebo effect can even kick in when there’s no placebo, according to
Dr. Fabrizio Benedetti, a professor at the University of Turin.

In one study, Benedetti hooked pain patients to a computerized injection
device. In some cases, the computer administered morphine without the
patients knowing it, and in others, a doctor gave the drug in full view.
The hidden therapy was much less effective than the open one, showing that
to get the most from a treatment, you have to know you’re getting it.

Similarly, Parkinson’s patients improved more when they were told doctors
were activating a stimulator in their brains than when the stimulator was
turned on without their knowing it, Benedetti showed.

In Alzheimer’s patients, however, the Italian team found the expectation of
pain relief did not reduce the perception of pain, suggesting that a mostly
healthy brain is required for the placebo effect to work.

Though all this makes for compelling research, it’s still unclear what it
means to patients and their doctors. “That’s the new frontier,” Harvard’s
Kaptchuk said.

What is clear is that having a reasonably positive attitude that a new
treatment will work can at least stack the odds in your favor, and not
focusing on all the possible side effects makes sense, too.

It’s also essential to pick a healthcare provider you trust so that his or
her words of encouragement about a treatment can boost the chance it will
work for you.

FDA loosens reins

January 10, 2000 by Judy Foreman

The US Food and Drug Administration once had the power to force manufacturers of over-the-counter dietary supplements, including herbal remedies, to prove those products were safe, if the agency felt such a pre-market review was warranted.

That changed in 1994, when Congress passed the Dietary Supplement Health and Education Act, which gives sellers of vitamins and herbs the freedom to tout the alleged benefits of their products without much FDA intervention.

Since DSHEA, it’s been possible to put a supplement on the market and keep it there until the FDA finds clear evidence that the product is harmful. Unlike drugs regulated by the FDA, dietary supplements and herbs do not have to be proven to be safe or effective to be sold.

Before DSHEA, all health claims on supplements – as on food – had to have FDA approval before marketing. Since DSHEA, manufacturers have been able to make “structure/function” claims without prior approval. That means they haven’t been able to say a product prevents a particular disease, like depression, but they can say something vague like the product is a “mood enhancer.”

But the vagueness of struc ture/ function claims has caused considerable confusion among consumers. In response to that, last week, the FDA issued a new ruling on disease claims, which takes effect in 29 days.

It states that a number of common conditions such as aging and pregnancy are normal life stages, not diseases, and therefore manufacturers can make structure/function claims for products aimed at them, says Peggy Dotzel, acting associate commissioner for policy at the FDA.

But some consumer advocates say the ruling is a blow to consumer protection. The change is a “huge weakening” of the previous FDA proposal, says Dr. Sidney M. Wolfe, director of Public Health Citizen Research Group in Washington, D.C. It is “a snake-oil exemption” and a “complete cave-in to the industry.”

On the other hand, industry representatives were delighted.

“The FDA has backed down from its previous, ill-considered proposal to redefine the word `disease’ by broadening it. . .to include nonpathological states that are a normal function of aging or the body,” said Mark Blumenthal, executive director of the American Botanical Council in Austin, Texas, a nonprofit research and education organization funded in part by the herbal industry.

Under the FDA’s original proposal, “menopause would be considered a disease. Even balding and graying of a beard would have been considered a disease,” he said.

In essence, he added, the final rule now “allows herbal products to continue making certain kinds of claims that might not have been able to be made had that definition of disease gone into final status.”

With manufacturing of herbal products, DSHEA requires only that manufacturers produce them in accordance with “good manufacturing practices” of the food industry. But there is a wide range of standards within the food regulations, which are often less stringent than those in the pharmaceutical industry.

The FDA is now writing more stringent manufacturing regulations for supplements and has sought comments from supplement makers and the public.

While the United States continues to struggle with ways to regulate the herbal industry, other countries have long had a better grip on things.

In Germany, herbal products are regulated largely as pharmaceuticals – both as prescription and over-the-counter drugs, notes John Cardellina of the Council for Responsible Nutrition, a Washington-based group representing the supplement industry. But, he adds, the German “approval process for drugs is not as stringent as the FDA approval process.”

Detecting, treating bladder cancer early

December 13, 1999 by Judy Foreman

Four years ago, Ellen Pinzur, a Cambridge woman who had been a lifetime smoker, got a most unwelcome surprise.

When she went to her gynecologist for a routine exam, he suspected she had a fibroid, a benign growth in the uterus. He sent her for an ultrasound. Sure enough, she did have a fibroid.    

But that was the good news.The test also showed that Pinzur, now 52, had bladder polyps. She had them removed, then several months later, had a checkup by cystoscopy, in which a urologist inserts a lighted tube through the urethra to see inside the bladder while the patient is under local anesthesia.

The polyps were gone, but they had “seeded” her bladder with cancerous tumors. Unlike many people who get bladder cancer, Pinzur did not have the telltale sign of blood in her urine.

In hopes of boosting the odds of beating her cancer, Pinzur joined a study in which tuberculosis bacteria, of all things, are squirted into the bladder to trigger an influx of white blood cells that attack both the TB and cancer cells. (The risk of TB spreading to other parts of the body is low.)

Perhaps because of this unusual therapy, Pinzur has been cancer-free now for two years.

The therapy she had is but one of a number of new techniques that scientists are working on to improve both treatment and diagnosis of bladder cancer, which will strike 54,200 Americans this year and kill 12,100. Men are four times more likely to get bladder cancer than women because smoking is a major trigger for the cancer, and historically, men have smoked more than women.

If caught early, while the cancer is a shallow spot in the lining of the bladder, the 5-year survival rate is 95 percent; for cancers that have invaded muscle tissue and spread throughout the body, 5-year survival is 50 to 60 percent.

But the most striking thing about bladder cancer is that it recurs in 70 percent of cases, no matter what doctors do. For the 500,000 Americans who have it, this means a lifetime of monitoring – including cystoscopy every three to 12 months.

This is not only unpleasant, it’s expensive – much more so than caring for someone with breast or prostate cancer, notes Dr. Ihor Sawczuk, vice chairman of urology at Columbia University’s College of Physicians and Surgeons.

But nearly a dozen new tests now on the market or under development could lighten this burden.

The goal of all these tests is “to make cystoscopy unnecessary,” says Dr. Kevin R. Loughlin, a urologist at Brigham and Women’s Hospital. So far, he cautions, none of the tests has replaced cytology – a noninvasive exam in which a pathologist looks through a microscope at cells shed from the bladder into the urine. If he or she sees any suspicious cells, the patient must then undergo cystoscopy, the more invasive test.

But cytology, the current “gold standard,” is not a perfect test. In fact, it picks up only about 40 percent of cancers, and is worst at spotting the most common, early stage bladder cancers.

The hope is the new tests can do much better.

Today , for instance, Matritech, Inc. of Newton will present its case to the US Food and Drug Administration, arguing for expanded approval of its already-marketed test, NMP22, which measures a protein made in the nucleus of cells in urine. High levels of NMP22 indicate high turnover of cells, a sign of cancer. The company wants doctors to use the test not just to monitor people who have cancer, as is now the case, but to test those who merely show symptoms, like having blood in the urine. In Japan, the NMP22 test is already approved for wider screening.

Overall, the test is 70 percent sensitive, which means it finds 70 percent of tumors at all stages of cancer combined.

That also means it misses 30 percent. And while that’s better than cytology, it’s still underwhelming to some urologists.

“It’s not the greatest test in the world,” says Dr. Michael O’Donnell, director of the bladder cancer center at Beth Israel Deaconess Medical Center. “I did a 6-month pilot trial at our institution and abandoned it.” The test often said patients had cancer when they didn’t and missed it in those who did have it.

Even if it were 80 percent sensitive, “that just isn’t good enough in my mind,” adds Loughlin of the Brigham.

Still, in one Italian study published last year, NMP22 was a better cancer detector than a marker called BTA. Another 1998 study found NMP22 was just as sensitive as a marker called telomerase, and that both were more sensitive than BTA. A Cleveland Clinic study published in January, showed the test was 100 percent sensitive. And a Spanish study, published this month suggested that NMP22 combined with another marker, CYFRA 21-1, can help reveal whether cystoscopy is needed.

For instance, if a patient scores low on the NMP22 test, it may be safe to postpone the invasive exam for a few months or do it under local anesthesia in the doctor’s office. If a patient scores high, it suggests the procedure should be done in a hospital under anesthesia, so that if the urologist does see cancer, he or she can remove it right then and there.

The NMP22 test may also tip the balance when other tests are ambiguous, notes Dr. Eric J. Sacknoff, a urologist at Cambridge Urological Associates. If the NMP22 score is high and a bladder X-ray is negative, for instance, that may indicate there is indeed a cancer, but higher up in the urinary system.

Ultimately, it’s not just better detection but better treatment that’s needed to turn the tide in bladder cancer.

At the Beth Israel, for instance, urologist O’Donnell is expanding the trial that Pinzur participated in to 70 centers nationwide. It’s already been shown that treating bladder cancer patients with TB seems to prevent recurrence in about 60 percent of cases. O’Donnell hopes that adding alpha interferon may improve those odds. So far, though, his study hasn’t followed patients long enough to tell.

Ultimately, says Loughlin of the Brigham, the best treatment for bladder cancer will probably be gene therapy to correct messages from errant genes on chromosomes 9 and 17. And the best way to prevent it is not to smoke. Scientists believe that bladder cancer begins when genes on one or both of these chromosomes are damaged by tobacco and other carcinogens.

So far, he says, that research is still in its infancy. But “this is where the real, major advance is going to be.”< SIDEBAR

SMOKERS AT HIGHER RISK YOU MAY BE AT RISK FOR BLADDER CANCER IF YOU ARE OVER 50, MALE OR SMOKE. IN FACT, MEN ARE FOUR TIMES MORE LIKELY THAN WOMEN TO GET BLADDER CANCER, PROBABLY BECAUSE, HISTORICALLY, THEY’VE BEEN MORE LIKELY TO SMOKE. MEN ALSO TEND TO URINATE LESS FREQUENTLY THAN WOMEN, WHICH MEANS THAT WHATEVER TOXINS OR CARCINOGENS ARE IN THE URINE STAY IN THE BLADDER LONGER. 

Smoking causes nearly half of bladder cancer deaths in men and more than a third in women. Others at risk include those who are exposed to chemicals called aromatic amines. Painters, as well as people who work in the leather, rubber, dye, and aluminum industries often use these compounds.

In recent years, the incidence of bladder cancer has been rising slowly, for unclear reasons.

One sign of possible bladder cancer is blood in the urine, either enough to see with the naked eye, or traces detected through urine testing. But this doesn’t always indicate cancer. It can also be – in fact, it usually is – a sign of infection or inflammation anywhere in the urinary tract, prostate problems, or a kidney stone. Or sometimes, simply having eaten beets can give the urine a reddish hue.

Still, if you have blood in your urine, you should call your doctor.

E-therapy is hardly a bargain

December 6, 1999 by Judy Foreman

We’ve got e-commerce, e-banking, e-pharmacy and of course, e-mail. So why not e-therapy?

Actually, there are lots of reasons why not. But that’s not stopping the latest trend in electronic medicine – virtual therapists, some 150 to 200 of them, who offer assessments, generic advice and even ongoing individual psychotherapy online.

The mere idea of sending private thoughts into cyberspace to someone who may or may not be a qualified therapist, who probably isn’t licensed in the state where you live and who can’t see the tears in your eyes when you talk about your mother is enough to send mainstream therapists around the bend.

And the whole notion might indeed be silly except for two things. One: Some people actually prefer confiding in a computer. And two: There’s a huge unmet need for mental health services in America, and Net-based services might help meet it.

Consider depression. Roughly 18 million Americans suffer from it and only two thirds get treatment. Indeed, a recent Harris poll showed that among 60 million Americans who used the Net last year to search for health information, what they most wanted to know about was depression.

There are several ways computer technology can help, and the least controversial is by offering diagnosis and assessment. At www.mediconsult.com, for instance, you can take a 10-minute test to help interpret your moods. I took it, and it’s not bad – on a par with standard questionnaires in self-help books. In other words, it might help clarify whether you need treatment – but obviously can’t provide warm, supportive feedback.

Another online assessment tool is being developed by Healthcare Technology Systems (www.healthtechsys.com) and is already available by telephone (1-800-813-2364). I took this, too, and for some reason, found it more disconcerting to punch in answers on the phone pad than to click on a computer form.

Still, it’s not assessment that’s really controversial in virtual psychotherapy, it’s the idea of being analyzed by a therapist you can’t see. This drawback might change with the advent of video-audio transmission via the Net.

Many therapists draw a distinction between using e-mail occasionally to stay in touch with patients they already know and conducting therapy between strangers on the Net.

Dr. Russell Lim , a psychiatrist at UC/Davis in California, uses e-mail in the former way. “I’m a pragmatist,” he says, and is quite willing to try “whatever works in real life.”

He uses e-mail with a patient who lives far away and comes in every other week, just as some therapists use the telephone to stay in touch when necessary. “Without the Internet connection,” he says, “the point might be lost.”

Other therapists, like University of Chicago psychiatrist Dr. Robert Hsiung (www.dr-bob.org/tips) haven’t used the Net yet for individual counselling, but do run virtual self-groups. For instance, Hsiung puts patients with similar problems in touch with each other and is excited about the “potential to do something more directly clinical online.”

But when virtual contact is the only or the primary mode of therapy, numerous questions arise, including the issue of online confidentiality.

Hsiung, for instance, acknowledges that “e-mail isn’t totally secure or confidential. You hope people realize that, but maybe not.” E-mail is fine for innocuous things like re-scheduling an appoinment, he says, but patients should “think twice before sending out sensitive information.”

But the “biggest drawback to online versus real life [therapy] is you don’t get the nonverbal cues, which are a big part of communication,” acknowledges psychologist John Grohol, who runs the mental health section of drkoop.com.

That means the therapist can’t detect a telltale whiff of alcohol on a patient’s breath, or the dirty clothes and hair of someone who’s too depressed to bathe, adds Dr. Ronald Pies, a Tufts University psychiatrist.

And if the therapist and patient have never met, it could be downright dangerous to perform therapy online, warns Gerald Koocher , chief psychologist at Children’s Hospital in Boston.

“The difficulty is when you don’t know who you’re dealing with or what the reality of the situation is,” he says, which is particularly crucial for patients who may be suicidal.

“Do you know who they are and where they are? Do you know how to get emergency services to them? If someone is in your office, you can call the police. If you’re on the phone and you know where they live, you can call intervention for them. If they’re on the Net, you may not know who you’re talking to or where they are or what the nearest emergency facility is.”

Patients, of course, are equally “blind” as to who an Internet therapist really is. “Anybody can hang up a shingle on the Net,” says Pies, which raises the risk of both bad therapy and fraud.

Moreover, psychiatrists, psychologists and social workers are licensed state by state. If if you were harmed by online therapy offered by someone in another state, where would you file a complaint or sue for malpractice?

Even www.metanoia.org, a website that offers lists of online therapists and does some checking of credentials, admits on its site that “if something goes drastically wrong as a result of your interaction with a therapist online, at the present time, you probably have little or no legal recourse against the therapist.”

In fact, metanoia concedes that e-therapy is not really therapy, though it says “it can definitely be therapeutic.”

Despite the serious drawbacks, some believe cybertherapy is an idea whose time has come.

“I personally think this technology has the most potential to improve the rates of treatment and overall quality of treatment of any technology since antidepressants,” says Dr. Joshua Freeman , a psychiatrist at UCLA and medical director for mental health at mediconsult.com.

As it is now, he says, “the system is failing if it insists on providing a certain type of treatment that most people don’t get.”

Besides, a number of studies suggest that some people feel more comfortable – and are more honest – when they’re “interviewed” by a computer rather than a human, especially about sensitive issues.

A 1987 study by University of Wisconsin researchers, for instance, examined the scores of 150 psychiatric patients on diagnostic interviews given both face to face with a trained interviewer and on a computer. A significant majority “liked the computer interview better and found it less embarrassing,” the researchers concluded.

Other studies compiled by Dr. John Greist, CEO of Healthcare Technology Systems, suggest that people may feel more comfortable confessing problems with alcohol, drug or sexual function to a computer because they can think before they answer and don’t have to worry about keeping a professional waiting. People with “social phobia” may also prefer a computer.

So where will all this lead? Let’s hope not too far.

Okay, online self-diagnosis tests are fine. And in a pinch, an online shrink might be better than none, though it’s inappropriate if you’re seriously ill or suicidal.

But basically, therapy is a complex, subtle human endeavor that would lose something essential in cyberspace.

In other words, I side with psychologist Barry Schlosser, who runs a consulting firm in New Haven called Clarity Consulting Corp. E-therapy, he says, is not “ready for prime time.”<
SIDEBAR

THERE ARE MANY WEB SITES OFFERING INFORMATION ON MENTAL HEALTH PROBLEMS AND GUIDANCE IN FINDING A THERAPIST. SOME YOU MAY WANT TO VISIT ARE:

www.healthtechsys.com (for information oncomputerized mental healthassessments)

www.mediconsult.com (for mental health assessment – click on depression, then on “mind health tracker”)

www.drkoop.com (for information on depression and other mental health problems)

http://mentalhelp.net (for information on mental health problems)

Trendy pill should be taken with a grain of salt

November 29, 1999 by Judy Foreman

She’s a young woman from the South Shore, finally able both to work and to study for an advanced degree.

But for years, she’s been plagued by severe depression that stems, she says, from physical abuse she suffered as a child, and from sexual abuse when she was 17.

She tried Prozac and, by her count, 30 other antidepressant drugs. Nothing worked. Psychotherapy helped some, and still does, but not enough.

She’s been suicidal. She still has nightmares and flashbacks. Until a few months ago, the woman, who did not want her age, occupation or town published, felt she had no options left.

Then she tried SAM-e, the European prescription antidepressant that in recent months has been growing here in popularity, despite its $10-a-day price tag. The preparation is now available as an over-the-counter remedy in US health food stores.

“I haven’t felt as depressed,” says the woman, who has been taking 800 milligrams a day of SAM-e for several months. “It sounds corny, but I just have experienced more joy lately.”

Neither an herb nor a vitamin, SAM-e (pronounced “Sammy”) is a synthetic form of a chemical made in the body from methionine, an amino acid, and an energy molecule called ATP. It helps with dozens of metabolic functions from preservation of cell membranes to DNA replication.

In fact, it’s been studied and used for years in Italy as an antidepressant. In the US, the potential market for it is huge – 18 million Americans suffer from depression.

Because it is sold as a dietary supplement, SAM-e did not have to pass safety or efficacy review by the US Food and Drug Administration. But because it contains a “new ingredient” (S-adenosylmethionine), manufacturers must inform the FDA of their intent to sell it. By law, if the FDA does not object within a defined time period – and it has not with SAM-e – the new ingredient may be sold.

It’s not at all clear how SAM-e might combat depression. It does not work as Prozac-type drugs do, by blocking re-uptake of a brain chemical called serotonin. It may act by improving the elasticity of cell membranes or by stabilizing receptors on cell membranes, but this is unproved.

Still, there’s evidence that some depressed people may be low in SAM-e, and that taking SAM-e supplements may help. In a 1990 study of 30 depressed people, one third had low levels of SAM-e in the cerebrospinal fluid, says Teodoro Bottiglieri, the leader of that research and director of the neuropharmacology lab at Baylor Institute of Metabolic Disease in Dallas.

Several animal studies and one placebo-controlled human study suggest that SAM-e can boost serotonin levels. Other evidence suggests SAM-e may also raise levels of dopamine and norepinephrine, two other brain chemicals often involved in depression.

But the best – albeit flawed – evidence for SAM-e comes from a 1994 Italian analysis of pooled data from 13 clinical trials. Taken together, six studies showed SAM-e was better than a placebo at reducing depression. The other studies suggested SAM-e was equal in efficacy to older, tricyclic antidepressants, which have been shown to be about as effective as newer antidpressants such as Prozac.

Yet even psychiatrists who recommend SAM-e are cautious.

“It is not a good first-line drug. It’s something to consider as a possible alternative when other things have failed,” says Dr. Maurizio Fava, a psychiatrist at Massachusetts General Hospital. So far, he says, most studies are too small to carry much statistical weight and use poorly defined groups of depressed patients.

Dr. Scott Ewing, director of the depression and anxiety disorders clinic at McLean Hospital in Belmont, agrees.

“Every year or so, there’s a new antidepressant du jour. Right now SAM-e is it. A couple of years ago, it was St. John’s wort,” he says. But SAM-e research “is not of the highest quality.”

The studies have typically followed patients for four weeks or less. Since many depressed patients feel better in a few weeks even taking a placebo, these results may be meaningless. A study that followed people for 8 to 12 weeks would be more convincing, say psychiatrists, because the placebo effect often wears off by this point.

Still, Ewing supports the use of SAM-e in his patients who can’t tolerate side-effects of other antidepressants, partly because it appears to have few side effects and to be safe.

It may also take effect sooner than standard antidepressants and may, if taken with them, boost their effectiveness, he says. But this is unproven, warns Ewing, and there are other ways to boost the potency of antidepressants for which there is good evidence.

Dr. Jerry Rosenbaum, associate chief of psychiatry for clinical research at MGH, keeps SAM-e for “situations where I’m striking out with the patient on side effects.” But even when it helps, he says, the benefits don’t always last.

On the other hand, Dr. Richard Brown, associate professor of clinical psychiatry at Columbia University in New York, is an unabashed SAM-e proponent. In his book [see sidebar], Brown calls SAM-e a “breakthrough supplement” and claims that it “begins to relieve depression in seven days.” In a telephone interview, he adds that he’s now treated hundreds of people with SAM-e.

In order for the body to make SAM-e, a person must have adequate levels of folate (which in turn is made from folic acid, a vitamin) and vitamin B-12. (In fact, adding folate to standard antidepressants may increase their benefit.)

Once it’s made, enzymes interact with SAM-e, causing it to give up a part of its chemical structure called a methyl group. In particular, SAM-e donates methyl groups to cell membranes, to big proteins inside cells and to small ones outside cells like the neurotransmitters serotonin, norepinephrine, and dopamine.

For instance, when lipids in cell membranes are well supplied with methyl groups, the membranes remain elastic, says Bottiglieri. This allows receptors in the membrane, including those for some neurotransmitters involved in depression, to move around as they need to, carrying chemical signals.

Still, nobody really understands how SAM-e might work in depression, so if you try it, do so under a doctor’s supervision, assuming you can find a doctor open-minded enough to read what research is available.

Because SAM-e is poorly understood, don’t try it if you have manic-depression, because some antidepressants may make mania worse. It’s also important to take tablets that are enterically coated so they dissolve in the intestines, not the stomach, where they can be absorbed, and that are foil-wrapped so they do not absorb moisture.

Also make sure that your SAM-e product contains 1,4-butanedislfonate, a stabilizer. If not stabilized, SAM-e products can degrade and become useless. In fact, that’s what happened a decade ago when MGH researchers Fava and Rosenbaum did a SAM-e study with 40 patients.

The study was “a bust,” they say, because the tablets they had ordered from Italy sat unrefrigerated over a hot weekend at Logan airport. The pills became discolored, suggesting oxidation, and perhaps because of this, patients who took them did no better than those on a placebo.

There’s also a theoretical possibility that SAM-e might raise levels of homocysteine, an amino acid that can raise the risk of heart disease.

And there’s one final caveat. Several US researchers now at the forefront of SAM-e research have in the past or are now planning to do research supported by Nature Made, which sells a SAM-e product.

This does not necessarily mean the researchers are unethical or their findings won’t be credible. But it’s something to chew on.

The unhealthy side of health concerns

November 22, 1999 by Judy Foreman

It’s been years now, but I can still picture the articulate young woman with the mysterious disease who came to the Globe to see me.   She was armed with a stack of medical papers and spoke with the ease of a scientist about possible causes, symptoms, and tests. But what was most striking was how much her identity seemed to be wrapped up in her illness.

I still have no idea what she may have had. She was clearly suffering – and angry. Yet she seemed unable to take comfort in the fact that her doctors could find nothing seriously wrong. In fact, she seemed stuck in what doctors call “the sick role.”      That’s a shame.

Granted, stories abound about people who stick to their guns, resist the bland reassurances of busy doctors and keep fighting until they get the right diagnosis. More power to them!

In fact, that’s what happened to Dr. Martin P. Solomon, a popular Boston internist who works for Affiliated Physicians Group, based at Beth Israel Deaconess Medical Center.

Twenty years ago, Solomon was worried about a mole on his arm. He consulted dermatologists – “the three biggest guys in the city” – and all told him it was nothing. He insisted that it be removed. Sure enough, it was a melanoma, a potentially deadly cancer. “Had I waited, I wouldn’t be here,” he says.

But still, much of the time, contends Solomon in his new, self-published book, “Don’t Worry, Be Healthy – How to Avoid Obsessing About Your Health,” the American fixation on understanding every hiccup has become downright unhealthy.

“Worry displaces joy,” says Solomon, who certainly sees enough patients – 30 to 40 a day – to know. “People push joy out of the way, from fear or from fatigue.”

The bottom line is as simple as it can be hard to swallow: Get yourself checked out if you’re worried about something, and get a second opinion and more tests if you’re really worried. But once you’ve done all that and everything appears fine, get on with your life, including addressing the emotional issues – anxiety, depression or simply stress – that might be causing your troubles, or at least, hampering your ability to cope with them.

The “sick role” is a terrible trap, and oddly enough, people who really have a serious disease may be less likely to fall into it than people who have no documentable illness.

In one study, Dr. Arthur Barsky, a psychiatrist and director of psychosomatic research at Brigham and Women’s Hospital, interviewed people waiting for medical appointments in a clinic, simply asking them to describe themselves.

People who were not deemed by doctors to be hypochondriacs (defined as people who are not faking their symptoms but can’t be reassured when nothing is wrong) tended to talk about themselves as teachers, parents or to describe their hobbies, even if they had cancer. Those who were considered to be hypochondriacs saw themselves as patients.

In a review published in June in the Annals of Internal Medicine, Barsky and Dr. Jonathan F. Borus, chairman of the department of psychiatry at the Brigham, note that it’s normal for healthy people to report physical complaints every few days.

“Significant fatigue” is a problem for more than 20 percent of healthy adults, and musculoskeletal problems, for 30 percent, they note. Indeed, 86 to 95 percent of the general population has at least one symptom such as a headache, dizziness or heart palpitations in any two- to four-week period.

In many cases, Barsky and Borus say, it’s the belief that one is sick that causes distress. In one study they reviewed, people who hadn’t known they had high blood pressure had a threefold increase in days of work lost once they were diagnosed.

In another, telling healthy volunteers they had tested positive for a disease caused them to recall symptoms characteristic of the disease and to think they had acted in ways that could have put them at risk. In yet another, Barsky and Borus note, people who signed informed-consent forms that specified certain gastrointestinal side effects of a treatment were more likely to experience those side effects than those whose forms did not specify those problems.

Sometimes, obsessing about bodily symptoms and conveying this distress to other people is an indirect way of asking for attention. But this can backfire because, to keep getting that attention, you have to stay in the “sick role.”

One way around that is to agree with your doctor that, even though there seems to be nothing wrong at the moment, you’ll come back in a specified number of weeks or months. That accomplishes two things: It allows a window for re-testing, in case you do have a serious disease. And it lets you let go of your need to be “sick” in order to see the doctor again.

Another solution is to tackle the emotional component of hypochondria head-on.

At the Brigham, Barsky is running a study sponsored by the National Institute of Mental Health to see whether six sessions of counselling using cognitive-behavioral techniques helps ease hypochondriacs’ distress. This approach aims at teaching people to spot what things – thoughts, situations, behaviors – make symptoms worse and which make them better.

At Harvard Vanguard Medical Associates, psychiatrist Dr. Steven Locke, chief of behavioral medicine, also runs a 6-week program. It’s geared toward people who have have stress-related symptoms like headaches, or diseases like asthma that are exacerbated by stress; those with chronic diseases like irritable bowel syndrome or cancer who have a hard time coping emotionally with their illnesses; and to those, like the woman who visited me at the Globe, who have persistent symptoms that defy medical explanation.

Dealing more directly with the emotional causes or consequences of illness can not only decrease distress, it can save a health care organization money. In one recent study at Kaiser Northwest in Albany, N.Y., people who participated in a mind-body program cost the system nearly $1,000 less a year than similar patients who were referred to the program but opted out.

But saving money is not the point. Finding contentment is, and that’s important whether you, or someone you love, has a serious disease or not – as Dr. Martin Solomon found out the hard way. For years, he took only two week’s vacation. “I always felt bad when I went away,” he says. “I felt I should be here seeing patients.”

Then, several years ago, his wife was diagnosed with lymphoma. So for their 25th anniversary, they took the trip to Italy they’d planned for their 30th. They bought a bigger house on Cape Cod to accomodate their grown daughters. He now takes six weeks a year off. “We’ve learned to enjoy walks on the beach. We do more things together,” he says.

“I don’t have to tell this to patients with cancer. They know it,” he adds. It’s the worried well who need to hear it.

ILL OR HEALTHY, DON’T ASSUME THE ‘SICK ROLE’

If you and your doctor have appropriately pursued the symptoms that distress you and there still seems to be no cause, take heart. At a minimum, you should know you’re in good company – an estimated 35 to 50 percent of visits to primary care doctors are for problems for which no physical cause can be found.

But that doesn’t mean you’re not suffering, and it doesn’t mean you are powerless, either. Here are some suggestions:

Don’t assume the “sick role.” This means not thinking of yourself as a patient, but instead defining yourself by who you really are – a parent, spouse, worker, friend, gardener, whatever.

If you do have genuine restrictions on what you can do because of pain, disability or fatigue, make realistic concessions to those limits, but focus on what you still can do.

If your doctor does the appropriate tests and does give you reassurance, try not to reject it. If you get angry when the doctor says you’re fine, look deeper into your feelings. Ditto if you find yourself substituting a new worry as soon as you let go of an old one.

Ask yourself what factors other than disease might be contributing to your symptoms. Do you hate your job? Are you fighting with your spouse? Are your kids acting out? Are you fretting about money? If so, the answer may be to focus on the problem that really needs attention, not your aching back.

Next Page »

Copyright © 2025 Judy Foreman